×
May 15, 2023 · During his inaugural speech, City of Hayward Mayor Mark Salinas said, "Your business will complement the STEM Centers of the middle and high ...
Missing: q= https% 3A% 2F% 2Fwww. 2Fnews-
7 days ago · The trial's primary objectives are to assess the safety and tolerability of the AAV vector-mediated gene therapy, while secondary objectives ...
Missing: q= 3A% 2F% 2Fwww. 2Fnews- 2Fgrand- opening- cmc- cdmo- facility- 301825132.
May 15, 2023 · ARUP Laboratories' companion diagnostic (CDx) for BioMarin Pharmaceutical Inc.'s hemophilia gene therapy, Roctavian, was approved by FDA.
Missing: q= 3A% 2Fwww. 2Fnews- releases% 301825132. html
May 16, 2023 · The company announced in a news release the new 20,000-square-foot facility containing cGMP suites, developmental and testing laboratories, ...
Missing: q= 2Fwww. prnewswire. 2Fnews- 2Fgrand- 301825132. html
May 16, 2023 · The 20,000 square foot facility containing cGMP suites, developmental and testing laboratories, equipped with single use bioreactors at 50 L, ...
Missing: q= https% 3A% 2F% 2Fwww. prnewswire. 2Fnews- 2Fgrand- 301825132. html
Oct 31, 2022 · With our new facility, Avirmax CMC Inc. is able to deliver high yield and quality vectors efficiently, timely and cost effectively. Avirmax ...
Missing: q= https% 2F% 2Fwww. 2Fnews- 2Fgrand- opening- 301825132.
8 hours ago · The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related ...
Missing: q= 2Fwww. 2Fnews- 2Fgrand- cmc- cdmo- facility- 301825132.
In order to show you the most relevant results, we have omitted some entries very similar to the 7 already displayed. If you like, you can repeat the search with the omitted results included.